SCOPUS 정보 검색 플랫폼

British Journal of Clinical Pharmacology

Volumn 61, Issue 4, 2006, Pages 470-473

A study of codispensing with sodium alendronate in Australia

(3) Boyd, Ian W a McEwen, John a Calcino, Lisa J b

a THERAPEUTIC GOODS ADMINISTRATION (Australia)

b Health Insurance Commission (Australia)

Author keywords

Adverse oesophageal effects; Alendronate; Calcitriol; Codispensing; Incidence

Indexed keywords

ALENDRONIC ACID; ANTACID AGENT; ANTIEMETIC AGENT; BISMUTH; CALCITRIOL; GASTROINTESTINAL AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; MISOPROSTOL; PROTON PUMP INHIBITOR;

ARTICLE; AUSTRALIA; COHORT ANALYSIS; DATA BASE; DRUG USE; HEALTH CARE ORGANIZATION; HUMAN; MEDICARE; PRESCRIPTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ALENDRONATE; AUSTRALIA; BONE DENSITY CONSERVATION AGENTS; CALCITRIOL; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; GASTROINTESTINAL AGENTS; GASTROINTESTINAL DISEASES; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; SEX DISTRIBUTION;

EID: 33645016356 PISSN: 03065251 EISSN: 13652125 Source Type: Journal
DOI: 10.1111/j.1365-2125.2006.02592.x Document Type: Article

Times cited : (1)

References (10)

1
- 0030278360
- Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis
- Tucci JR Tonino RP Emkey RD Peverly CA Kher U Santora IIAC Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis Am J Med 1996 101 488 501
- (1996) Am J Med , vol.101 , pp. 488-501
- Tucci, J.R.¹ Tonino, R.P.² Emkey, R.D.³ Peverly, C.A.⁴ Kher, U.⁵ Iiac, S.⁶

2
- 0004851872
- Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
- Black DM Cummings SR Karpf DB Cauley JA Thompson DE Nevitt MC Bauer DC Genant HK Haskell WL Marcus R Ott SM Torner JC Quandt SA Reiss TF Ensrud KE Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures Lancet 1996 348 1535 41
- (1996) Lancet , vol.348 , pp. 1535-41
- Black, D.M.¹ Cummings, S.R.² Karpf, D.B.³ Cauley, J.A.⁴ Thompson, D.E.⁵ Nevitt, M.C.⁶ Bauer, D.C.⁷ Genant, H.K.⁸ Haskell, W.L.⁹ Marcus, R.¹⁰ Ott, S.M.¹¹ Torner, J.C.¹² Quandt, S.A.¹³ Reiss, T.F.¹⁴ Ensrud, K.E.¹⁵

3
- 0034723772
- Upper gastrointestinal tract safety profile of alendronate
- Bauer DC Black D Ensrud K Thompson D Hochberg M Nevitt M Musliner T Freedholm D Upper gastrointestinal tract safety profile of alendronate Arch Intern Med 2000 160 517 25
- (2000) Arch Intern Med , vol.160 , pp. 517-25
- Bauer, D.C.¹ Black, D.² Ensrud, K.³ Thompson, D.⁴ Hochberg, M.⁵ Nevitt, M.⁶ Musliner, T.⁷ Freedholm, D.⁸

4
- 0010496839
- Esophagitis associated with the use of alendronate
- De Groen PC Lubbe DF Hirsch LJ Daifotis A Stephenson W Freedholm D Pryor-Tillotson S Seleznick MJ Pinkas H Wang KK Esophagitis associated with the use of alendronate N Engl J Med 1996 335 1016 21
- (1996) N Engl J Med , vol.335 , pp. 1016-21
- De Groen, P.C.¹ Lubbe, D.F.² Hirsch, L.J.³ Daifotis, A.⁴ Stephenson, W.⁵ Freedholm, D.⁶ Pryor-Tillotson, S.⁷ Seleznick, M.J.⁸ Pinkas, H.⁹ Wang, K.K.¹⁰

5
- 2942553744
- A gut feeling for alendronate
- ADRAC.
- ADRAC. A gut feeling for alendronate Aust Adv Drug React Bull 1999 18 3
- (1999) Aust Adv Drug React Bull , vol.18 , pp. 3

6
- 0031894591
- United Kingdom experience with alendronate and oesophageal reactions
- Mackay FJ Wilton LV Pearce GL Freemantle SN Mann RD United Kingdom experience with alendronate and oesophageal reactions Br J General Pract 1998 48 1161 2
- (1998) Br J General Pract , vol.48 , pp. 1161-2
- MacKay, F.J.¹ Wilton, L.V.² Pearce, G.L.³ Freemantle, S.N.⁴ Mann, R.D.⁵

7
- 0034507704
- Impact of increasing the re-supply interval on the seasonality of subsidised prescription use in Australia
- Donnelly N McManus P Dudley J Hall W Impact of increasing the re-supply interval on the seasonality of subsidised prescription use in Australia Aust NZ J Public Health 2000 24 603 6
- (2000) Aust NZ J Public Health , vol.24 , pp. 603-6
- Donnelly, N.¹ McManus, P.² Dudley, J.³ Hall, W.⁴

8
- 2942605810
- Bisphosphonate use and subsequent prescription of acid suppressants
- Roughead EE McGeechan K Sayer GP Bisphosphonate use and subsequent prescription of acid suppressants Br J Clin Pharmacol 2004 57 813 6
- (2004) Br J Clin Pharmacol , vol.57 , pp. 813-6
- Roughead, E.E.¹ McGeechan, K.² Sayer, G.P.³

9
- 0033021313
- Examining the adequacy of quantities available for subsidized antidepressant prescriptions in Australia
- McManus P Mant A Birkett D Hemming M Lindner J Examining the adequacy of quantities available for subsidized antidepressant prescriptions in Australia Pharmacoepidemiol Drug Safety 1999 8 191 5
- (1999) Pharmacoepidemiol Drug Safety , vol.8 , pp. 191-5
- McManus, P.¹ Mant, A.² Birkett, D.³ Hemming, M.⁴ Lindner, J.⁵

10
- 0031656970
- Compliance with restrictions on the susidized use of proton pump inhibitors in Australia
- McManus P Marley J Birkett DJ Lindner J Compliance with restrictions on the susidized use of proton pump inhibitors in Australia Br J Clin Pharmacol 1998 46 409 11
- (1998) Br J Clin Pharmacol , vol.46 , pp. 409-11
- McManus, P.¹ Marley, J.² Birkett, D.J.³ Lindner, J.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.